Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results (2013)
- Authors:
- USP affiliated authors: JORGE, RODRIGO - FMRP ; MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP
- Unidade: FMRP
- Subjects: DOENÇAS RETINIANAS; CÉLULAS-TRONCO; ESTUDOS PROSPECTIVOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
ARCIERI, R. S. et al. Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results. 2013, Anais.. Seattle: ARVO, 2013. . Acesso em: 30 dez. 2025. -
APA
Arcieri, R. S., Messias, K., Castro, V. M., Siqueira, R. C., Jorge, R., & Messias, A. M. V. (2013). Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results. In Abstracts. Seattle: ARVO. -
NLM
Arcieri RS, Messias K, Castro VM, Siqueira RC, Jorge R, Messias AMV. Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results. Abstracts. 2013 ;[citado 2025 dez. 30 ] -
Vancouver
Arcieri RS, Messias K, Castro VM, Siqueira RC, Jorge R, Messias AMV. Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results. Abstracts. 2013 ;[citado 2025 dez. 30 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
